Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin

Allan D. Kirk^*, Roslyn B. Mannon, David E. Kleiner, John S. Swanson, Robert L. Kampen, Linda K. Cendales, Eric A. Elster, Terri Wakefield, Christine Chamberlain, Steven C. Hoffmann, Douglas A. Hale

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review